With the introduction of "Made in China 2025" and the inclusion of ten industries with high performance medical devices in the "national strategy", C&G Medical, which failed to make a run for the GEM and then switched to the New Third Board market, is expected to take advantage of the east wind of the national industrial support policy to accelerate its development. The reporter recently found that the company focused on the development and production of nuclear magnetic resonance imaging (MRI) radio frequency coils and other core components have recently successfully developed a 1.5T superconducting magnets, is expected to achieve domestic import substitution in the medical field. The company has recently successfully developed 1.5T superconducting magnets, which are expected to achieve domestic import substitution in the medical field. C&G Medical is mainly engaged in the research and development, design, production, sales and maintenance of RF coil products and its accessories, which are core components of MRI. Chairman Wang Jie said in a recent interview that Centron has the core technology of R&D and production of the third generation array MRI RF coils and the fourth generation MRI SENSE RF coils, with 54 related patents, including 6 invention patents, filling the gap of China in this field of science and technology. It is worth noting that in October this year, the company's new 1.5T magnetic resonance superconducting magnets were successfully developed, which will achieve the replacement of imported similar products in the medical field. Magnetic resonance imaging system as a high-end medical imaging products, its most important components are superconducting magnets, radio frequency, gradient system and computer software parts. It is reported that 1.5T MRI superconducting magnets account for 30% to 40% of the total cost of MRI systems, 3.0T MRI superconducting magnets account for 50% to 60% of the total cost of MRI systems, superconducting magnets due to its special design, the complexity of the process, and the need for comprehensive engineering capabilities, high technology threshold has led to the domestic has not formed a stable supply of superconducting magnet products, and has long been The high technology threshold has led to the lack of a stable domestic supply of superconducting magnets, which has long been monopolized by foreign countries. Therefore, the market has been calling for 1.5T, 3.0T superconducting magnets to meet the needs of domestic customers and form a stable supply to occupy the high-end of the industrial value chain. A medical services industry experts interviewed by reporters said, "Centron Medical 1.5T magnetic resonance superconducting magnet development and production will significantly reduce the high price of superconducting magnetic resonance system, to expand the scope of application, to solve the problem of difficult and expensive medical care for the people to play a role in promoting." Wang Jie further said, "Centron's superconducting magnets have a wide application space, not only for medical MRI equipment, but also will be widely used in various scientific and technological fields, including high-end scientific instruments, industrial superconducting magnets and national large scientific projects." The market is in short supply and the industry space is huge So how big is the magnetic resonance market space, and how much can Centron Medical's superconducting magnet business share in the future? The reporter interviewed Dr. Tang Hongming, director of the Magnet Division of Centron Medical, and learned that the global MRI market size was about $3.65 billion in 2015, with Siemens, Philips and General Market share reaching about 80%. For domestic purposes, the demand for superconducting MRI is about 800 units/year, and with an average market price of 5 million yuan/unit, the current domestic MRI (medical and research) market capacity is about 4 billion. "It is expected that in the next five years, China's 1.5T and 3.0T MRI products will rapidly industrialize to seize the international market and break the monopoly position of international giants in this market." Tang Hongming said. According to Tang Hongming, it is expected that by next year, Centron's 1.5T superconducting magnet sales will reach 20 units, and with an estimate of 1.3 million yuan per unit, the sales revenue can reach 26 million yuan, but the domestic market demand is expected to be 200 units, with huge market space. Another concern is that Centron 3.0T superconducting magnets are expected to be successfully developed in the first half of next year, when Centron will occupy the industrial high ground in the field of superconducting magnets, comparable to internationally renowned superconducting magnet suppliers. 3.0T superconducting magnets are expected to produce 3 to 5 units by the end of 2016, with each unit costing about 2.5 million yuan. Financial data show that C&G Medical achieved operating revenues of RMB 65.54 million, RMB 76.26 million and RMB 30.08 million in 2013, 2014 and the first half of this year, respectively, and net profits of RMB 13.25 million, RMB 15.97 million and RMB 5.1 million. At present, the company's revenue is still dominated by magnetic resonance radio frequency coil business, the future 1.5T, 3.0T superconducting magnets mass production will form the company's main profit growth point. Tang Hongming told reporters that the market space for superconducting magnets is huge, and even by 2018, the market is still in short supply. "There are already several foreign MRI system integrators negotiating with Centron. The company will expand its production capacity in a controlled manner according to the orders, that is, on the basis of ensuring technology and building brand, gradually amplify the pace of industrialization of the company."